Novartis Jacked Up Painkiller Prices, Class Action Claims
Law360, Los Angeles (January 2, 2014, 7:40 PM EST) -- Novartis AG was hit with a proposed consumer class action in New Jersey federal court Tuesday claiming the Swiss pharmaceutical giant sells a popular over-the-counter migraine medication at a higher price than an identical product marketed under a different name.
Named plaintiff Kerri Yingst alleges that Novartis sells the painkiller Excedrin Migraine at a higher price than Excedrin Extra Strength, which has an identical formulation and dosage. Yingst, of Cherry Hill, N.J., bought Excedrin Migraine repeatedly during the past eight years to treat her recurrent migraines, according to the class action complaint.
"Defendants' conduct is a proximate cause of plaintiff's and...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!